210 related articles for article (PubMed ID: 15766301)
1. Pharmacoeconomic analysis of sertraline treatment of depression in patients with unstable angina or a recent myocardial infarction.
O'Connor CM; Glassman AH; Harrison DJ
J Clin Psychiatry; 2005 Mar; 66(3):346-52. PubMed ID: 15766301
[TBL] [Abstract][Full Text] [Related]
2. Sertraline treatment of major depression in patients with acute MI or unstable angina.
Glassman AH; O'Connor CM; Califf RM; Swedberg K; Schwartz P; Bigger JT; Krishnan KR; van Zyl LT; Swenson JR; Finkel MS; Landau C; Shapiro PA; Pepine CJ; Mardekian J; Harrison WM; Barton D; Mclvor M;
JAMA; 2002 Aug; 288(6):701-9. PubMed ID: 12169073
[TBL] [Abstract][Full Text] [Related]
3. Sertraline for treatment of depression in acute coronary syndromes.
Lespérance F; Frasure-Smith N
JAMA; 2002 Nov; 288(19):2403; author reply 2403-4. PubMed ID: 12435245
[No Abstract] [Full Text] [Related]
4. Sertraline for treatment of depression in acute coronary syndromes.
Steinberg DI
JAMA; 2002 Nov; 288(19):2403; author reply 2403-4. PubMed ID: 12435244
[No Abstract] [Full Text] [Related]
5. Onset of major depression associated with acute coronary syndromes: relationship of onset, major depressive disorder history, and episode severity to sertraline benefit.
Glassman AH; Bigger JT; Gaffney M; Shapiro PA; Swenson JR
Arch Gen Psychiatry; 2006 Mar; 63(3):283-8. PubMed ID: 16520433
[TBL] [Abstract][Full Text] [Related]
6. A pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes in Spain.
Gómez-Gerique JA; Casciano R; Stern L; Rejas J
Eur J Health Econ; 2004 Oct; 5(3):278-84. PubMed ID: 15714350
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression.
Lydiard RB; Stahl SM; Hertzman M; Harrison WM
J Clin Psychiatry; 1997 Nov; 58(11):484-91. PubMed ID: 9413414
[TBL] [Abstract][Full Text] [Related]
8. A claims analysis comparing citalopram with sertraline as initial pharmacotherapy for a new episode of depression: impact on depression-related treatment charges.
McLaughlin TP; Eaddy MT; Grudzinski AN
Clin Ther; 2004 Jan; 26(1):115-24. PubMed ID: 14996524
[TBL] [Abstract][Full Text] [Related]
9. Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS.
Lyketsos CG; DelCampo L; Steinberg M; Miles Q; Steele CD; Munro C; Baker AS; Sheppard JM; Frangakis C; Brandt J; Rabins PV
Arch Gen Psychiatry; 2003 Jul; 60(7):737-46. PubMed ID: 12860778
[TBL] [Abstract][Full Text] [Related]
10. Cost-utility comparison of escitalopram and sertraline in the treatment of major depressive disorder.
Armstrong EP; Skrepnek GH; Haim Erder M
Curr Med Res Opin; 2007 Feb; 23(2):251-8. PubMed ID: 17288678
[TBL] [Abstract][Full Text] [Related]
11. Course and cost of treatment for depression with fluoxetine, paroxetine, and sertraline.
Russell JM; Berndt ER; Miceli R; Colucci S; Grudzinski AN
Am J Manag Care; 1999 May; 5(5):597-606. PubMed ID: 10537866
[TBL] [Abstract][Full Text] [Related]
12. Long-term costs of treatment for depression: impact of drug selection and guideline adherence.
Crown WH; Treglia M; Meneades L; White A
Value Health; 2001; 4(4):295-307. PubMed ID: 11705297
[TBL] [Abstract][Full Text] [Related]
13. Treatment of depression following acute myocardial infarction.
Carney RM; Jaffe AS
JAMA; 2002 Aug; 288(6):750-1. PubMed ID: 12169081
[No Abstract] [Full Text] [Related]
14. Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial.
Cooper-Kazaz R; Apter JT; Cohen R; Karagichev L; Muhammed-Moussa S; Grupper D; Drori T; Newman ME; Sackeim HA; Glaser B; Lerer B
Arch Gen Psychiatry; 2007 Jun; 64(6):679-88. PubMed ID: 17548749
[TBL] [Abstract][Full Text] [Related]
15. Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression.
Murray V; von Arbin M; Bartfai A; Berggren AL; Landtblom AM; Lundmark J; Näsman P; Olsson JE; Samuelsson M; Terént A; Varelius R; Asberg M; Mårtensson B
J Clin Psychiatry; 2005 Jun; 66(6):708-16. PubMed ID: 15960563
[TBL] [Abstract][Full Text] [Related]
16. Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression.
Ravindran AV; Guelfi JD; Lane RM; Cassano GB
J Clin Psychiatry; 2000 Nov; 61(11):821-7. PubMed ID: 11105734
[TBL] [Abstract][Full Text] [Related]
17. A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia.
Thase ME; Fava M; Halbreich U; Kocsis JH; Koran L; Davidson J; Rosenbaum J; Harrison W
Arch Gen Psychiatry; 1996 Sep; 53(9):777-84. PubMed ID: 8792754
[TBL] [Abstract][Full Text] [Related]
18. Effect of sertraline on the recovery rate of cardiac autonomic function in depressed patients after acute myocardial infarction.
McFarlane A; Kamath MV; Fallen EL; Malcolm V; Cherian F; Norman G
Am Heart J; 2001 Oct; 142(4):617-23. PubMed ID: 11579351
[TBL] [Abstract][Full Text] [Related]
19. Psychiatric characteristics associated with long-term mortality among 361 patients having an acute coronary syndrome and major depression: seven-year follow-up of SADHART participants.
Glassman AH; Bigger JT; Gaffney M
Arch Gen Psychiatry; 2009 Sep; 66(9):1022-9. PubMed ID: 19736359
[TBL] [Abstract][Full Text] [Related]
20. Heart rate variability in acute coronary syndrome patients with major depression: influence of sertraline and mood improvement.
Glassman AH; Bigger JT; Gaffney M; Van Zyl LT
Arch Gen Psychiatry; 2007 Sep; 64(9):1025-31. PubMed ID: 17768267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
